fda crackdown on compounded semaglutide proposes curbs mass compounding of Novo, Lilly's weight-loss drugs Counterfeit Ozempic Crackdown: Drugmakers Threaten

The GLP-1 receptor exists in multiple tissues, including immune cells, and theoretical concerns exist about GLP-1 medications potentially modulating immune responses

During the Hims Q3 2024 earnings call, Dudum confirmed the company had already confirmed a core supplier for generic liraglutide, a drug whose branded version is sold by Novo Nordisk under the brand names Victoza and Saxenda for Type 2 diabetes and weight loss, respectively

Hi, my name is Pamela

Depressive symptoms and increased anxiety due to diabetes-related distress (i.e., the emotional and psychological burden associated with managing diabetes [140] are associated with poor self-care behaviors and worse intermediate and long-term health outcomes [218]